Gainesville, FL (PRWEB) November 12, 2004
The Mammatech Corporation (MAMH.OB) announced today a 20 to 1 reverse split in the company's shares of common stock effective 22 November 2002. The CompanyÂs 8k stated that it intends to seek financing for new product development. H.S. Pennypacker, Ph.D., President of Mammatech, said, "The company is developing a computer assisted tactile trainer that will help produce and verify high levels of clinical breast examination (CBE) skill.Â
Dr. Mark K. Goldstein, Mammatech's Chairman, reported that published studies continue to find that most breast cancers are first detected by someone's hands. The CompanyÂs MammaCareÂ® program is a recognized standard for proficient CBE.
- The MammaCareÂ® program was developed under grants from the National Cancer Institute.
- Barton, M. B., Harris, R., & Fletcher, S. W. (1999). Does this patient have breast cancer? The screening clinical breast examination: Should it be done? How? Journal of the American Medical Association, 282(13), 1270-1280.
Mark Goldstein, Ph.D.
(352) 375 0607
Company website http://www.mammacare.com
Email address firstname.lastname@example.org
The companyÂs transfer agent is
Manhattan Transfer Registrar Company
57 Eastwood Road,
Miller Place, NY 11764